U.S. racial and ethnic participation in global clinical trials by therapeutic areas

WHAT IS KNOWN AND OBJECTIVE: The discussion about health equity in the United States frequently involves concerns over racial and ethnic minority under‐representation in clinical trials and particularly in trials conducted in support of product approvals. The FDA has long worked to encourage diverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Lolic, Milena, Araojo, Richardae, Okeke, Melvyn, Temple, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290725/
https://www.ncbi.nlm.nih.gov/pubmed/34544200
http://dx.doi.org/10.1111/jcpt.13532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290725/
https://www.ncbi.nlm.nih.gov/pubmed/34544200
http://dx.doi.org/10.1111/jcpt.13532

Ejemplares similares